Bristol-Myers lays off the last 63 staffers at ZymoGenetics, shutters Seattle operations
Bristol-Myers Squibb has sounded the bell on what remains of storied Seattle biotech ZymoGenetics.
As ZymoGenetics vacates the Lake Union Steam Plant building that it has called home since 1993, it’s laying off 63 employees, according to a WARN notice filed last week. Bought out for $885 million in 2010 when Bristol-Myers still had an interest in virology, the group had been focused on discovery and early manufacturing for the New York-headquartered big pharma’s research team.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
